The document contains revised revenue forecasts for GlaxoSmithKline (GSK) from 2014 to 2020, detailing key categories and brands. It includes estimates for respiratory, oncology, CVMU, dermatology, anti-bacterials, rare diseases, vaccines, and consumer health products.
documents/vol00010-efta01457562-pdf.pdf
{"title":"GSK Revenue Forecasts","document_date":"May 2015","document_type":"tabular","key_locations":["London"],"document_subtype":"financial forecast","key_organizations":["GlaxoSmithKline","Deutsche Bank"],"reference_numbers":["DB-SDNY-0117159","SDNY_GM_00263343","EFTA01457562"]}